Revenue segments as reported by the company.

Instruments & Accessories

Systems

Services

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Intuitive Surgical

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Intuitive Surgical reports robust Q4 performance and eyes future growth

Intuitive Surgical's Q4 2022 showcased strong performance and growth in procedures and system placements.
While facing challenges like macroeconomic uncertainty and supply chain costs, the company is poised for continued innovation.
Opportunities lie in expanding markets, advancing technology, and improving surgical outcomes through collaboration.
Investments in industrial scale, automation, and platform advancements signal a strategic focus on future growth.

Intuitive Surgical (ISRG) reports robust Q1 performance and growth outlook

Intuitive Surgical (ISRG) delivered strong Q1 results with revenue up 14% and exceeding procedure growth expectations.
While facing challenges in manufacturing and supply chain, the company is focusing on R&D progress and inventory replenishment.
The outlook for 2023 looks promising with increased procedure growth forecasts and a focus on improving patient outcomes and market expansion.
Overall, Intuitive Surgical (ISRG) is well-positioned to capitalize on opportunities for growth and innovation in the robotic surgery market.

Intuitive Surgical excels in Q2 performance, eyes AI opportunities

Intuitive Surgical's Q2 2023 performance showcased strong revenue growth, procedure increases, and a focus on healthcare improvement.
The company's strengths include innovative ecosystem investments, commitment to patient outcomes, and advanced surgical technologies.
Challenges include market disruptions from new drugs, expense management, and adapting to changing healthcare landscapes.
Opportunities in AI, market expansion, and new procedures position Intuitive Surgical for continued growth and innovation.

Intuitive Surgical excels in Q3, eyes global expansion and margin growth

Intuitive Surgical's Q3 performance reflects strong growth and strategic focus on innovation and market expansion. Despite challenges in specific procedure categories and pricing dynamics, the company is well-positioned to capitalize on opportunities for growth and margin improvement.

Intuitive Surgical posts strong 2023 results, da Vinci 5 launch ahead

Intuitive Surgical's 2023 performance reflects strong revenue growth, operational excellence, and a strategic focus on innovation with the upcoming da Vinci 5 launch.
While facing challenges in operating margin pressure and supply chain issues, the company is well-positioned to capitalize on opportunities in soft tissue surgery, big data integration, and leased placements.
Investors should monitor how Intuitive Surgical navigates the launch of da Vinci 5, manages operational challenges, and leverages growth opportunities to sustain its market leadership.
Overall, Intuitive Surgical's Q4 earnings call highlights a resilient business model, customer-centric approach, and a commitment to advancing surgical technology for better patient outcomes.

Intuitive Surgical posts robust Q1 results amidst global market challenges

Intuitive Surgical delivered strong Q1 results with notable procedure and revenue growth, despite challenges in certain markets.
The company's focus on newer platforms, operational efficiency, and strategic outlook for 2024 positions it for continued success.
Addressing challenges and seizing opportunities in global markets and product innovation will be key for sustained growth and competitiveness.

Intuitive Surgical excels in Q2, eyes global expansion and innovation

Intuitive Surgical's Q2 performance reflects strength in procedure growth and system platform advancements.
The company's commitment to innovation and value creation positions them well for future success.
Challenges include sustaining margins and navigating market dynamics, while opportunities lie in expansion and innovation.
Overall, Intuitive Surgical's focus on growth, technology, and patient care sets a positive trajectory for the future.

Intuitive Surgical excels in Q3 with strong growth and innovation

Intuitive Surgical's Q3 2024 performance reflects a company in a strong position with notable achievements in procedures, financials, and technological advancements. While facing challenges in margin progression and international expansion, the company is well-positioned to leverage opportunities in innovation and customer insights.

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical NASDAQ: ISRG manufactures the revolutionary da Vinci Surgical System, the leader in robotic-assisted surgery systems. Da Vinci is turning 23 years old this year, with over 10 million surgeries worldwide performed since its launch in 1995.

Intuitive Surgical Gives Buying Opportunity Off Its 52 Week Highs

Upstart Holdings

Growth stocks are still seeing plenty of volatility, but some companies stand out from the pack. Intuitive Surgical has withstood many a market storm thanks to a simple but compelling business model.

Got $1,500? 2 Top Growth Stocks to Buy Right Now

Teladoc

Teladoc is a significant player in the virtual healthcare industry with promising prospects. Intuitive Surgical is a market leader in the rapidly expanding robotic surgery market, and it may remain so for some time.

2 Revolutionary Stocks I'd Buy Right Now Without Hesitation

GE HealthCare Technologies Inc

Inmode Ltd

Johnson & Johnson

CNBC's Jim Cramer predicts a booming bull market for medical devices, with positive earnings reports across the space. INMD, JNJ, ISRG and GEHC can emerge as potential winners.

Solid Earnings Fuel Potential Bull Market in Medical Devices

Fiverr

Healthcare and the gig economy are two explosive industries that show few signs of slowing down. Intuitive Surgical is profitable and maintains a sizable market share in robotic surgery.

2 Incredible Growth Stocks That Could Make a Comeback in 2023

Intuitive Surgical (ISRG) outperforms the industry and the S&P 500 Index due to its strength in robotics.

Intuitive Surgical (ISRG) Hits 52-Week High: What's Driving It?

Vita Coco

Novo Nordisk

Shockwave Medical

Stryker

Because of their longevity, predictability, and stability, healthcare trends can persist for years. The companies covered today are fundamentally and technically robust stocks currently taking advantage of these trends.

3 Healthcare Trends to Ride for Longevity

ABB Ltd.

iRhythm Technologies

The ever expanding role of robotics is making it an ideal time to find the top robotics stocks to buy. Robots, once confined to science fiction, have become a critical part of our daily lives.

The 3 Most Promising Robotics Stocks to Buy in May 2023

Dorian LPG

New highs for a stock are bullish. Three stocks are making it to new highs.

Warren Buffett's Berkshire Hathaway And Two More Stocks Hit New Highs

Abbott Labs

There is more to the comparison, and in the sections below, we discuss why we believe ISRG stock will offer higher returns than ABT stock in the next three years.

Which Healthcare Stock Is A Better Pick: Abbott Or This Robotic Products Company?

CoStar Group

Can You Still Buy the Nasdaq's Best-Performing April Stocks?

This minimslly invasive surgey specialist controls about 80% of its market share. Revenue and profits keep growing.

3 Things About Intuitive Surgical That Smart Investors Know

Microsoft

Microsoft is leveraging AI capabilities to strengthen its presence in internet search and cloud-computing businesses. Intuitive Surgical uses AI to improve the surgical capabilities of its da Vinci system.

AI Could Be a $14 Trillion Opportunity by 2030: Here Are 2 No-Brainer Stocks to Buy Now

Amazon

iRobot

The robot revolution is well underway and only growing in size and scope. Increasingly, robots are being used to help with everything from cleaning our floors to performing medical procedures.

3 Robotics Stocks to Buy for Futuristic Growth Potential

Intuitive Surgical reported strong Q1 earnings, beating Wall Street's expectations. The company's da Vinci surgical systems continue to disrupt the surgical procedures market.

Why Intuitive Surgical Stock Soared 18% Higher in April

Chipotle

Universal Health Services

Chipotle Mexican Grill, Universal Health Services, and Intuitive Surgical soared last month. All three companies reported positive first-quarter results in April.

Can You Still Buy the S&P 500's Best-Performing April Stocks?

Johnson & Johnson has kept its business stable and dividend consistent for years. Intuitive Surgical has a bright future in the minimally invasive surgery market.

Better Growth Stock: Johnson & Johnson vs. Intuitive Surgical

Intuitive Surgical is recovering from the headwinds caused by the pandemic. Its surgical systems are being deployed globally at a fairly quick clip.

This Cathie Wood Growth Stock Is on a Bull Run -- but Is It a Buy?

Barclays

Investors who target stocks displaying relative strength often find themselves in favorable trends, no matter the direction of the general market.

These 3 Large-Caps Roared in April

AbbVie

AbCellera Biologics

Cloudflare

AI is advancing everything from health care to banking. This isn't new, but it is hitting the mainstream consciousness.

How AI Is Revolutionizing Tech, and Why You Should Invest in These Leading Companies

SUNNYVALE, Calif., April 28, 2023 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and pioneer of robotic-assisted surgery, announced that the Food and Drug Administration recently cleared the da Vinci SP surgical system for simple prostatectomy as a representative procedure, which expands the urologic surgical procedures cleared by FDA.

Intuitive receives FDA clearance of da Vinci SP for simple prostatectomy

McKesson

Danaher

Eli Lilly

Moderna

UnitedHealth Group

Healthcare stocks are one of the best bets out there. The U.S. spends more on healthcare than any other country.

7 Healthcare Stocks With Huge Return Potential for Long-Term Investors

Tesla

Artificial Intelligence is a game-changer in the technology industry so it's time to consider stocks that represent the AI future. With the advent of ChatGPT and other generative AI technologies, investors cannot afford to ignore this sector any longer.

The 3 Most Surprising AI Breakthroughs for Investors to Watch

Intuitive Surgical is the leading maker of robotic surgical systems. The pandemic set back procedures as hospitals dealt with Covid cases.

Buy This Top Growth Stock Before the Next Bull Market

Booking Hlds

NVIDIA

Until interest rates started increasing in 2022, companies disrupting industries were very popular with investors. Think FAANG stocks and others.

News for Intuitive Surgical Stock (ISRG)